SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : E*Trade (NYSE:ET)
ET 16.93+2.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phil Tran who wrote ()6/2/2000 3:23:00 AM
From: Phil Tran   of 13953
 
How The Pros Use Wall Street Research
By Brett D. Fromson
Chief Markets Writer
6/1/00 7:29 PM ET

In an age when many Wall Street research departments are little more than
tools of their firms' investment banking units, how can the investor best use
their work to make money? You cannot simply dismiss their work because
it can move stock prices. On the other hand, you would be unwise to rely on
their buy recommendations.

To better understand how to exploit, or avoid, the avalanche of sell-side
research raining down on investors, I talked to a quartet of professional
investors who get paid to beat the market. These are men and women
whose livelihoods depend on getting market and stock picks right. So, it's
instructive to learn how they use sell-side research.

The first thing they tell you about Wall Street stock research is that you
should never, ever base an investment decision on an analyst's
recommendation. (In the euphemistic lingo of Wall Street, a strong buy
means buy the thing. A hold means sell. And a sell means you should have
sold already. My colleague Dagen McDowell recently deciphered this
lexicon for readers.)

"We don't listen to any of their opinions," says one hedge fund manager
based in midtown Manhattan who has outperformed the S&P 500 in each of
the past three years and so far this year too. "They have very useful facts
and allow us to leverage all the legwork they do, but at the end of the day, it
is our judgement and not theirs about the stocks we buy. They help fill in
the mosaic for a particular investment idea. We then have to make the
judgement about whether the analysis makes sense or not. Their analyses
are worth noting, but you should discount their buy recommendations
almost entirely."

Her partner chimes in that it's important to be on the alert for the amazing
"herd mentality" of the analytical community, too, which can magnify the
effects of the lead cow's move.

It was not always quite so bad, he notes. Once upon a time in the era of
fixed brokerage commissions, Wall Street firms were rewarded for providing
unique research. Customers paid full commissions in exchange for good
stock ideas. And research departments were supported by those
commissions, not entirely from the money that the investment bankers were
hauling in. Now, brokerage commissions are far lower, which is great; but an
unintended side effect has been the rise of the cattle call by analysts.

"In the old days," he adds, "there were more sell-side boutiques that got
rewarded for helping the investor understand a company or a stock from a
different point of view. That doesn't happen now. Now, you have many people
saying the same thing at the same time. No one is rewarded for sticking his
neck out on a call." Today, analysts rarely make 180-degree turns.
Sometimes they never change their tunes at all. Combine gradualism with
the common wisdom and you can get research that fails to alert you to
trouble ahead.

Take, for example, the cattle call on Exodus (EXDS:Nasdaq), an Internet
services provider whose stock price peaked at 179 5/8 on March 24, and
then collapsed to a low of 52 1/2 last week. (It closed Wednesday at 79
1/4.) The "consensus" Wall Street recommendation, according to First Call,
was that Exodus was a buy in late March at 179, a buy in early April at 146,
a buy in late April at 90, and, of course, a buy in late May at 52 1/2.

"I guarantee you that when Exodus started falling, the analysts reiterated
their buys," says another investment manager who runs a small hedge fund.

This guy describes what he calls the typical research cycle for a stock like
Exodus.

"Here is how it works," he says. "You have a stock that trades for months or
years at, say, $20-$25 a share on low volume. Then it breaks out on, say 3
million shares, way higher volume and closes at 26. The 'generals,' by which
I mean the Fidelitys and Putnams, are buying. The stock goes to 30 on
this buying. Most people, including the big sell-side firms, still don't really
care too much about the stock. But the Fido's of the world are consistently
buying on any pullbacks. Then the company announces all of a sudden a
pickup in earnings and revenue. All of a sudden, the analysts say the
company has reported a good number and they raise their earnings
estimates a bit and half the analysts upgrade their buy recommendations.
The stock goes to 40. Then they get guidance from the company in the next
quarter that business may be even better, and the analysts raise earnings
estimates again. Then the other analysts raise their recommendations.

"Now comes the big kicker -- the momentum players, the momo guys,
come in and take the stock from 65 to 90. Now the press starts writing
about the company. It makes the cover of Forbes or Fortune or Business
Week. Some analyst sets a new price target of 125. Meanwhile, the Fidos
and Putnams begin selling into the rallies. The company beats estimates
one more time, but the company warns that because it is building a new
factory it may only meet the new higher estimates next quarter. That's the
ballgame. Estimates are not going up anymore, so the momo guys sell. The
analysts have not changed their recommendations, but the game is over.
That is the cycle that gets played out every day in the market."

So what is an investor to do? Wise up.

If you are a trader, you want to keep up with the Wall Street estimates for
the company because they can whipsaw a stock up or down. Find out who
the "ax" on a stock is -- the analyst who can move a stock price because
he or she is seen to have great access to company management. For
instance, Goldman Sachs analyst Rick Sherlund is the ax on Microsoft
(MSFT:Nasdaq). Read what he or she writes, even if you disagree with it.

How do you recognize an analyst who is little more than a shill for his firm's
investment banking division, whose analysis is aimed at helping land more
underwriting from the covered company?

It's pretty simple. If a company announces really bad news, and the stock
goes down, and an analyst spins the news positively, be suspicious.
"Number don't lie. People lie," says the small hedge fund manager. "How a
stock price reacts to news, good or bad, is more important that what an
analyst has to say about the news."

Beyond the analysts who covers specific stocks, there are the market
strategists. Professional investors say that strategists like Morgan Stanley
Dean Witter's Byron Wien and Merrill Lynch's Bob Farrell, DLJ's Tom
Galvin or Paine Webber's Ed Kerschner can also be helpful, if only to
provoke you into thinking about the market's mood music. These guys have
been around a long time, have good access to top investors and, even if
they are dead wrong, are usually interesting.

Forget their "recommended lists," which are designed for institutional
investors who feel the need to be 100% in stocks all the time. As one hedge
fund manager says, "Do you think they own their buy lists?"

¸ 2000 TheStreet.com, All Rights Reserved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext